Precision-cut liver slices as a model for the evaluation of host-targeting agents against hepatitis B and delta viruses
Roca Suarez, A. A.; Michelet, M.; Dubois, A.; Diederichs, A.; Plissonnier, M.-L.; Heintz, S.; Saez-Palma, M.; Fletcher, S. P.; Rivoire, M.; Phillips, S.; Palma, E.; Chokshi, S.; Zoulim, F.; Testoni, B.
Show abstract
Developing new therapeutic strategies against hepatitis B virus (HBV) and hepatitis delta virus (HDV) is essential to cure these infections. Yet evaluation of host-targeting agents (HTAs) with in vitro and in vivo models remains challenging. Therefore, we assessed precision-cut liver slices (PCLS) as an HBV/HDV co-infection model to study virus-host interactions and HTAs. Our ex vivo PCLS infection protocol allows to establish HBV and HDV infection within the livers three-dimensional architecture. Treatment with two well-characterized HTAs produced distinct antiviral effects consistent with each mechanism: Bulevirtide blocked entry; Lonafarnib induced intracellular hepatitis delta antigen accumulation. The TLR8 agonist Selgantolimod showed anti-HBV activity not previously seen in cultured hepatocytes, indicating crosstalk between immune and infected cells within PCLS. These results provide the first characterization of PCLS as an ex vivo model of HBV/HDV co-infection and antiviral testing. Thus, PCLS could expedite pre-clinical HTA characterization against viral liver diseases while reducing animal experimentation.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A Human Liver Organoid Screening Platform for DILI Risk Prediction 94%
- Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell Reprogramming 92%
- The potent broadly neutralizing antibody VIR-3434 controls Hepatitis B and D Virus infection and reduces HBsAg in humanized mice 92%
Similar papers in this journal
- Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers predicting HBsAg loss 92%
- Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2 89%
- Comparative infectivity and pathogenesis of emerging SARS-CoV-2 variants in Syrian hamsters 89%
Similar papers in this journal
- Assessing Human Liver Spheroids as a Model for Antiviral Drug Evaluation Against BSL-3 Haemorrhagic Fever viruses 91%
- Abemaciclib restricts HCMV replication by suppressing pUL97-mediated phosphorylation of SAMHD1 89%
- Combinations of approved oral nucleoside analogues confer potent suppression of alphaviruses in vitro and in vivo 89%
Similar papers in this journal
- Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in-vivo CAR-T therapy for inflamm-aging 90%
- Broad-spectrum antiviral inhibitors targeting pandemic potential RNA viruses 89%
- Dynamic control of metabolic zonation and liver repair by endothelial cell Wnt2 and Wnt9b revealed by single cell spatial transcriptomics using Molecular Cartography 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.